SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ORTC Ortec International

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tummus1 who wrote (218)12/17/1998 10:33:00 PM
From: Jake  Read Replies (1) of 272
 
Same Jake. In addition to the cryopreservative milestone there is one other expected piece of news. They should be hooking up with a marketing partner soon.

What stymies me is that we have had a tremendous pick up in volume and the stock really has not moved up very much. This means that we are not seeing normal retail activity.

One other thing that I can think of. They had a setback earlier this year when they realized that the way that they treated burns was not consistent with the way that burns were treated at burn centers. They recently hired a burns specialist as an advisor. Maybe they have solved this problem in a way that puts them back on track.

Both ATIS and ORG have higher valuations than ORTC. If ORTC doubles it will still have a value of less than half of ORG. Now this doesn't make a whole lot of sense since one can say that ORTC is about 9 months away from FDA approval with a better product. ORTC's product will have a shelf life of 6 months and ORG's has almost no shelf life.

In late August (maybe September) the board authorized a stock buy back program.

That's all that I can think of. Maybe they have some breakthrough news to announce. I hope that it happens soon. It would make for a very merry Xmas.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext